Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiro Tatetsu

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 23, 2003
[Allergic reaction against an emulsifier, HCO-60, contained in multamin and enocitabine]Hiro Tatetsu, Norio Asou, Miki Nakamura, et al.
Leukemia & Lymphoma|January 7, 2006
Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cellsMiki Nakamura, Tomomi Gotoh, Yutaka Okuno, et al.
International Journal of Oncology|September 25, 2008
Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloidYoshitaka Kikukawa, Yutaka Okuno, Hiro Tatetsu, et al.
Leukemia & Lymphoma|June 30, 2023
Robust prognostic value of histologic transformation in patients with early progression of follicular lymphomaTakafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 8, 2022
[Follicular T-cell lymphoma successfully treated with long-term corticosteroid]Hiro Tatetsu, Daisuke Imakane, Kisato Nosaka, et al.
Ejhaem|July 18, 2022
Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphomaTakafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, et al.
Leukemia Research|May 13, 2008
Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factorHiro Tatetsu, Fumihiko Matsuno, Noritaka Takatsu, et al.
Molecular Cancer Therapeutics|July 16, 2005
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent mannerHiro Tatetsu, Yutaka Okuno, Miki Nakamura, et al.
Biochemical and Biophysical Research Communications|March 29, 2017
A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivoNao Nishimura, Shinya Endo, Shikiko Ueno, et al.
Blood|January 5, 2013
Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complexChong Gao, Todor Dimitrov, Kol Jia Yong, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 23, 2003
[Allergic reaction against an emulsifier, HCO-60, contained in multamin and enocitabine]Hiro Tatetsu, Norio Asou, Miki Nakamura, et al.
Leukemia & Lymphoma|January 7, 2006
Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cellsMiki Nakamura, Tomomi Gotoh, Yutaka Okuno, et al.
International Journal of Oncology|September 25, 2008
Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloidYoshitaka Kikukawa, Yutaka Okuno, Hiro Tatetsu, et al.
Leukemia & Lymphoma|June 30, 2023
Robust prognostic value of histologic transformation in patients with early progression of follicular lymphomaTakafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 8, 2022
[Follicular T-cell lymphoma successfully treated with long-term corticosteroid]Hiro Tatetsu, Daisuke Imakane, Kisato Nosaka, et al.
Ejhaem|July 18, 2022
Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphomaTakafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, et al.
Leukemia Research|May 13, 2008
Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factorHiro Tatetsu, Fumihiko Matsuno, Noritaka Takatsu, et al.
Molecular Cancer Therapeutics|July 16, 2005
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent mannerHiro Tatetsu, Yutaka Okuno, Miki Nakamura, et al.
Biochemical and Biophysical Research Communications|March 29, 2017
A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivoNao Nishimura, Shinya Endo, Shikiko Ueno, et al.
Blood|January 5, 2013
Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complexChong Gao, Todor Dimitrov, Kol Jia Yong, et al.
Pageof 5